News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • South Korea will use emergency measures to avert a Samsung strike, warning a single day's halted chip production could cost 1 trillion won.
  • Lee and Japan's Prime Minister Takaichi will hold a summit to boost economic and security cooperation and stabilize supply chains.
  • Report says China's manufacturing scale gives it an edge to capture most robotics economic value, pressuring global supply-chain competitors.
  • Australian treasurer defends capital gains tax overhaul as necessary to correct housing bias and shift investment toward equities.
  • U.S. prosecutors and regulators probe unusual wagers on political prediction markets, increasing legal risk for platforms and traders.
  • Bernstein finds AI will likely raise productivity in European business services, implying earnings upside rather than mass job cuts.

Latest Articles

Stifel Lowers Pool Corp Price Target After Q4 Miss, Keeps Hold Rating

Stifel Lowers Pool Corp Price Target After Q4 Miss, Keeps Hold Rating

Stifel reduced its price objective for Pool Corporation to $232 from $240 while maintaining a Hold rating after the company reported fourth-quarter 2025 results that missed forecasts and issued initial fiscal 2026 guidance below the consensus low. The stock plunged 13.2% on the news, narrowing its valuation gap with peers as the firm flagged persis…

UBS Lowers Cogent Communications Price Target Citing Slower Waves Rollout

UBS Lowers Cogent Communications Price Target Citing Slower Waves Rollout

UBS cut its price objective on Cogent Communications (CCOI) to $21 from $27 while retaining a Neutral rating, pointing to a slower-than-expected ramp in the company's waves business. The stock has plunged sharply over the past year. Recent quarterly results showed modest sequential revenue weakness, an EBITDA improvement driven in part by T-Mobile …

Stifel Lowers Snowflake Price Target as Margin Guidance Raises Questions

Stifel Lowers Snowflake Price Target as Margin Guidance Raises Questions

Stifel reduced its price target on Snowflake Inc. to $225 from $280 while maintaining a Buy rating, citing margin guidance that implies sequential compression. The firm highlighted strong bookings, 125% net revenue retention and migration activity that support mid-20% product revenue growth for fiscal 2027, and estimates roughly $5.5 billion in pro…

Stifel Lifts Tenaris Price Target to $57 After Strong Q4 2025 Results

Stifel Lifts Tenaris Price Target to $57 After Strong Q4 2025 Results

Stifel has raised its price target on Tenaris S.A. (NYSE:TS) to $57 from $45 while maintaining a Buy rating after the company reported fourth-quarter 2025 results that modestly exceeded consensus and outperformed Stifel's projections. Revenue and adjusted EBITDA beat Stifel's estimates by 3.1% and 15.5%, respectively. Management guided first-quarte…

Bernstein SocGen Keeps TJX at Outperform, Sets $170 Target

Bernstein SocGen Keeps TJX at Outperform, Sets $170 Target

Bernstein SocGen Group reiterated an Outperform rating on The TJX Companies with a $170.00 price target, noting the retailer's consistency and quality. The stock trades at $158.23, near its 52-week high, while UBS also reaffirmed a Buy and projected double-digit EPS growth over the next five years. Analysts point to expanding higher-income customer…

Bernstein SocGen Lowers Wayfair Target, Flags Margin and Comparison Risks

Bernstein SocGen Lowers Wayfair Target, Flags Margin and Comparison Risks

Bernstein SocGen Group reduced its price target on Wayfair Inc. (NYSE: W) to $100 from $105 and left its Market Perform rating intact after the company reported a fourth quarter that largely met expectations but included softer gross-margin commentary. The firm highlighted tougher year-over-year comparisons and the potential for gross-margin compre…

Stifel nudges Trex price target higher to $37.50 while keeping Hold rating

Stifel nudges Trex price target higher to $37.50 while keeping Hold rating

Stifel raised its price target on Trex Company Inc. (NYSE:TREX) to $37.50 from $35.00 while retaining a Hold rating, saying the company is taking appropriate steps to restore momentum. The firm cautioned that the factors behind the weakness after the third quarter of 2025 have not been fully resolved, even as Trex now trades at a premium to buildin…

Psyence Biomedical to Exchange Shares with Psyence Labs in $5M Equity Swap

Psyence Biomedical to Exchange Shares with Psyence Labs in $5M Equity Swap

Psyence Biomedical Ltd. (NASDAQ:PBM) said it will acquire 2,900 shares of Psyence Labs Ltd. through a share-for-share exchange after Psyence Labs exercised a previously disclosed put option. The Labs shares are valued at $5 million using a per-share fair market valuation of $1,724. In return, Psyence Biomedical will issue 1,146,159 common shares to…

MoonLake Shares Rise After Positive Phase 2 axSpA Data for Sonelokimab

MoonLake Shares Rise After Positive Phase 2 axSpA Data for Sonelokimab

MoonLake Immunotherapeutics saw its stock climb in premarket trading after disclosing topline results from the Phase 2 S-OLARIS study of sonelokimab in axial spondyloarthritis (axSpA). The data showed high rates of clinical response at Week 12, corroborated by PET and MRI imaging, while the safety profile remained consistent with earlier studies. T…

UK government says Trump’s 15% global tariff unlikely to hit most of UK-US trade

UK government says Trump’s 15% global tariff unlikely to hit most of UK-US trade

The UK government does not expect U.S. President Donald Trump’s newly announced 15% global tariff to affect the majority of trade covered by last year’s UK-U.S. economic agreement, Prime Minister Keir Starmer’s spokesman said. British and U.S. officials are set to continue discussions this week after the U.S. Supreme Court struck down previous tari…

Armata Shares Tick Higher After FDA Grants QIDP Status to Phage Candidate

Armata Shares Tick Higher After FDA Grants QIDP Status to Phage Candidate

Armata Pharmaceuticals saw premarket gains after the U.S. Food and Drug Administration awarded Qualified Infectious Disease Product (QIDP) designation to AP-SA02, its multi-phage intravenous candidate for complicated Staphylococcus aureus bacteremia. The designation confers regulatory incentives, including five years of market exclusivity and eligi…